Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Gallbladder Neoplasms × Geriatric Assessment × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1 Gallbladder Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

Gemcitabine 3 Cisplatin 3 Oxaliplatin 2 pertuzumab 1 durvalumab 1 Trastuzumab 1 Standard of Care 1 Paclitaxel 1 Geriatric Assessment 1 Everolimus 1 Drug Therapy 1 Capecitabine 1 ARRY-334543 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06999512 2025-05-31

HPB70+

Assistance Publique - Hôpitaux de Paris

Phase 2/3 Not yet recruiting

Gastrointestinal

Gallbladder Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡